Survival from Diagnosis Early Mortality and Recorded Systemic Therapy Lines in a Turkish Small Cell Lung Cancer Analytic Cohort
Background/Objectives: We described survival from diagnosis, early mortality, and recorded systemic therapy lines and explored the association between baseline brain metastases and mortality in a Turkish small cell lung cancer (SCLC) cohort. Methods: This retrospective single-center study included 131 eligible adults. Observed diagnoses ranged from 12 August 2009 to 23 May 2023. All included patients had died by follow-up ascertainment. Additional brain-metastasis analyses and calendar-period comparisons were exploratory and post hoc. Treatment calendar details, immunotherapy exposure, and cranial radiotherapy details were unavailable. Results: Median overall survival (OS) was 10.41 months (95% confidence interval [CI], 8.74–13.04); 30- and 90-day mortality were 5.3% and 12.2%. First-line platinum–etoposide was recorded in 99 patients (75.6%). Of 22 limited-stage patients, 21 received concurrent thoracic chemoradiotherapy with curative intent; one patient could not start anticancer therapy after pneumonia and rapid clinical deterioration. Within extensive-stage disease, the unadjusted brain-metastasis hazard ratio (HR) was 1.67 (95% CI, 0.98–2.86; p = 0.061), the log-rank p value was 0.059, and the adjusted HR was 1.98 (95% CI, 1.07–3.66; p = 0.029). A 5000-replicate bootstrap gave a percentile 95% CI of 1.10–4.87 and a bias-corrected and accelerated (BCa) 95% CI of 0.84–3.79. The original full-cohort brain-metastasis p value was 0.033 and became 0.099 after Bonferroni or Holm adjustment across three baseline findings. Conclusions: The analyses suggested a possible association between baseline brain metastases and higher mortality, but the original full-cohort association did not meet the significance threshold after Holm correction. Sparse exposure and unmeasured confounding make this finding hypothesis-generating. Clinic-based referral selection may limit generalizability.
Authors
- Oğuzhan Kesen (ORCID: https://orcid.org/0000-0001-8279-7188)
- Ali Çelik (ORCID: https://orcid.org/0000-0003-2363-1844)
Institutions
- Recep Tayyip Erdoğan University (TR)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/jcm15229083
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00